Runway Growth Finance funds two investments in Q2

“Runway Growth delivered portfolio expansion in the second quarter while maintaining our disciplined approach to underwriting and credit quality,” said David Spreng, CEO. “As we evaluate the current late- and growth-stage market, we are confident that more high-quality companies are seeking non-dilutive capital to advance their strategic roadmaps. Our borrowers continue to generate strong performance in the existing operating environment, and we look forward to partnering with additional companies. We have a strong, actionable pipeline of attractive investments and believe we are well-positioned to execute on the right transactions in the second half of 2024.” In the second quarter of 2024, Runway Growth funded two investments in new portfolio companies. These include: Completion of a $58.4 million investment to a new portfolio company in the marketing technology industry that is an enterprise SaaS platform focused on customer engagement for mobile apps, funding $58.4 million at transaction close; an Completion of a new $56.1 million senior secured term loan commitment to Onward Medical, funding $17.1 million at close. Onward is a medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injuries. During the second quarter ended June 30, 2024, Runway Growth experienced one prepayment totaling $25.3 million and scheduled principal amortization of $1.3 million. The prepayment included: Full principal repayment of the Company’s senior secured term loan to Turning Tech Intermediate, of $25.3 million.